Advertisement

Topics

Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update

12:07 EDT 15 May 2018 | Investing News Network

Cesca Therapeutics (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced financial and operating results for the first quarter ended March 31, 2018, and provided a corporate update. As quoted in the press release: “Since our acquisition of SynGen in July of last year, we have made substantial progress … Continued

The post Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update appeared first on Investing News Network.

Original Article: Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update

NEXT ARTICLE

More From BioPortfolio on "Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...